Investigating treatments for lung disease in premature infants
Neonatal Research Network Data Coordinating Center (DCC) 2023-2028
This study is looking at how preterm babies who are at risk for lung problems grow and develop over time, especially those who are part of a trial testing a medication called hydrocortisone, so that parents and teachers can better support them as they reach school age.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project ID | NIH-11074073 on NIH RePORTER |
What this research studies
This research focuses on understanding the long-term respiratory and developmental outcomes of preterm infants who are at high risk for bronchopulmonary dysplasia (BPD). It builds on an ongoing clinical trial that is testing the effects of hydrocortisone on these infants. By following a large group of children until they reach early school age, the study aims to provide valuable insights into their functional abilities and challenges. This information will help parents and educators support these children effectively as they grow.
Who could benefit from this research
Good fit: Ideal candidates for this research are preterm infants who are at high risk for developing bronchopulmonary dysplasia.
Not a fit: Patients who are not preterm or do not have a diagnosis of bronchopulmonary dysplasia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and support for children affected by bronchopulmonary dysplasia.
How similar studies have performed: Previous studies have shown success in similar approaches, particularly in understanding the long-term outcomes of preterm infants with respiratory challenges.
Where this research is happening
Research Triangle Park, United States
- Research Triangle Institute — Research Triangle Park, United States (Active)
Researchers
- Principal investigator: Das, Abhik — Research Triangle Institute
- Study coordinator: Das, Abhik
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.